SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -30.85%2.57M | -17.20%2.45M | 5.97%2.68M | -12.20%12.74M | 41.00%3.54M | 30.67%3.72M | -24.16%2.96M | -51.90%2.53M | -82.75%14.51M | -75.71%2.51M |
Operating revenue | -30.85%2.57M | -17.20%2.45M | 5.97%2.68M | -12.20%12.74M | 41.00%3.54M | 30.67%3.72M | -24.16%2.96M | -51.90%2.53M | -82.75%14.51M | -75.71%2.51M |
Cost of revenue | -6.25%975K | 4.98%844K | 15.11%975K | -47.15%3.94M | 28.67%1.25M | -27.58%1.04M | -63.55%804K | -70.24%847K | -76.10%7.46M | -76.20%973K |
Gross profit | -40.41%1.59M | -25.46%1.61M | 1.37%1.71M | 24.77%8.8M | 48.80%2.29M | 90.12%2.68M | 27.05%2.16M | -30.27%1.68M | -86.67%7.05M | -75.38%1.54M |
Operating expense | -0.56%6.7M | -16.66%5.65M | -32.70%5.69M | -41.33%29.48M | -21.35%7.5M | -41.58%6.74M | -50.14%6.78M | -45.67%8.45M | -30.18%50.24M | -42.60%9.54M |
Selling and administrative expenses | 5.59%5.48M | -11.80%4.63M | -32.29%4.61M | -41.80%22.85M | -26.94%5.61M | -40.40%5.19M | -51.21%5.25M | -43.87%6.81M | -26.84%39.26M | -35.31%7.68M |
-Selling and marketing expense | -5.11%780K | -17.44%691K | -46.26%532K | -28.49%3.58M | -16.35%931K | -28.58%822K | -35.91%837K | -31.06%990K | -49.41%5.01M | -45.87%1.11M |
-General and administrative expense | 7.61%4.7M | -10.73%3.94M | -29.91%4.08M | -43.75%19.27M | -28.74%4.68M | -42.20%4.37M | -53.33%4.41M | -45.59%5.82M | -21.74%34.26M | -33.10%6.56M |
Research and development costs | -21.13%1.22M | -33.25%1.03M | -34.43%1.08M | -39.62%6.63M | 1.72%1.89M | -45.22%1.55M | -46.11%1.54M | -52.04%1.64M | -39.96%10.97M | -60.80%1.86M |
Operating profit | -25.66%-5.11M | 12.55%-4.05M | 41.17%-3.98M | 52.12%-20.68M | 34.83%-5.21M | 59.88%-4.06M | 61.14%-4.63M | 48.50%-6.77M | -126.93%-43.18M | 22.86%-8M |
Net non-operating interest income expense | 80.14%-475K | -181.02%-6.25M | 86.87%-183K | -84.34%-7.2M | -30.95%-1.19M | -443.64%-2.39M | -92.30%-2.22M | 0.43%-1.39M | 51.14%-3.91M | 52.23%-911K |
Non-operating interest expense | -80.14%475K | -85.34%326K | -86.87%183K | 84.34%7.2M | 30.95%1.19M | 443.64%2.39M | 92.30%2.22M | -0.43%1.39M | -51.14%3.91M | -52.23%911K |
Total other finance cost | ---- | --5.92M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other net income (expense) | -94.74%2K | 200.00%5K | -75.90%-292K | 97.20%-123K | 104.03%10K | 101.75%38K | 99.75%-5K | -166K | 55.84%-4.4M | 96.74%-248K |
Special income (charges) | --0 | --0 | 36.54%-290K | 83.19%-157K | --300K | --0 | --0 | ---457K | 90.71%-934K | --0 |
-Less:Restructuring and merger&acquisition | --0 | --0 | -36.54%290K | -51.07%457K | --0 | --0 | --0 | --457K | -90.89%934K | --0 |
-Less:Impairment of capital assets | ---- | ---- | ---- | ---500K | ---- | ---- | ---- | ---- | ---- | ---- |
-Less:Other special charges | ---- | ---- | ---- | --200K | ---- | ---- | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | -94.74%2K | 200.00%5K | -100.69%-2K | 100.98%34K | -16.94%-290K | 103.06%38K | 99.75%-5K | --291K | -3,561.00%-3.46M | -122.46%-248K |
Income before tax | 13.06%-5.58M | -50.07%-10.29M | 46.48%-4.46M | 45.62%-28M | 30.16%-6.4M | 49.64%-6.42M | 54.41%-6.86M | 42.73%-8.33M | -39.18%-51.49M | 53.98%-9.16M |
Income tax | 0 | 0 | 0 | -190.91%-80K | 0 | 0 | -600.00%-100K | -80.00%20K | -42.48%88K | -133.99%-52K |
Net income | 13.06%-5.58M | -52.29%-10.29M | 46.61%-4.46M | 45.86%-27.92M | 29.76%-6.4M | 49.72%-6.42M | 55.13%-6.76M | 42.98%-8.35M | -38.85%-51.57M | 54.59%-9.11M |
Net income continuous Operations | 13.06%-5.58M | -52.29%-10.29M | 46.61%-4.46M | 45.86%-27.92M | 29.76%-6.4M | 49.72%-6.42M | 55.13%-6.76M | 42.98%-8.35M | -38.85%-51.57M | 54.59%-9.11M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 13.06%-5.58M | -52.29%-10.29M | 46.61%-4.46M | 45.86%-27.92M | 29.76%-6.4M | 49.72%-6.42M | 55.13%-6.76M | 42.98%-8.35M | -38.85%-51.57M | 54.59%-9.11M |
Preferred stock dividends | 0.00%2.24M | 0.00%2.24M | 0.00%2.24M | 0.00%8.95M | 0.00%2.24M | 0.00%2.24M | 0.00%2.24M | 0.00%2.24M | 0.00%8.95M | 0.00%2.24M |
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 9.68%-7.82M | -39.28%-12.53M | 36.76%-6.7M | 39.08%-36.87M | 23.89%-8.63M | 42.30%-8.66M | 48.00%-8.99M | 37.28%-10.59M | -31.30%-60.53M | 49.10%-11.34M |
Basic earnings per share | 93.31%-1.77 | 89.67%-2.85 | 95.13%-1.65 | 78.86%-49.5 | 91.09%-3.3668 | 52.31%-26.47 | 62.98%-27.6 | 53.50%-33.9 | -5.33%-234.15 | 62.50%-37.8 |
Diluted earnings per share | 93.31%-1.77 | 89.67%-2.85 | 95.13%-1.65 | 78.86%-49.5 | 91.09%-3.3668 | 52.31%-26.47 | 62.98%-27.6 | 53.50%-33.9 | -5.33%-234.15 | 62.50%-37.8 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |